NCT06355206 Natural Course and Therapeutic Effect of Recurrent Acute Pancreatitis
| NCT ID | NCT06355206 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Changhai Hospital |
| Condition | Cohort Study |
| Study Type | OBSERVATIONAL |
| Enrollment | 2,000 participants |
| Start Date | 2024-04-22 |
| Primary Completion | 2034-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 2,000 participants in total. It began in 2024-04-22 with a primary completion date of 2034-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational cohort study is to learn about the etiology, natural course, therapeutic effect and outcome of recurrent acute pancreatitis patients. The main question it aims to answer is: Does endoscopic intervention, surgery or conservative treatment reduce the recurrence of acute pancreatitis? What are the risk factors affecting the recurrence of acute pancreatitis? Patients will be closely followed and clinical information will be recorded.
Eligibility Criteria
Inclusion Criteria: * Patients with recurrent acute pancreatitis. Exclusion Criteria: * Unwilling or unable to provide consent.
Contact & Investigator
Zhaoshen Li, M.D.
STUDY CHAIR
Changhai Hospital
Frequently Asked Questions
Who can join the NCT06355206 clinical trial?
This trial is open to participants of all sexes, studying Cohort Study. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06355206 currently recruiting?
Yes, NCT06355206 is actively recruiting participants. Contact the research team at lianghao-hu@smmu.edu.cn for enrollment information.
Where is the NCT06355206 trial being conducted?
This trial is being conducted at Shanghai, China.
Who is sponsoring the NCT06355206 clinical trial?
NCT06355206 is sponsored by Changhai Hospital. The principal investigator is Zhaoshen Li, M.D. at Changhai Hospital. The trial plans to enroll 2,000 participants.